Particularly, we found that the distribution of renal cancer patients with low-risk values was relatively concentrated, which could be well distinguished from renal cancer patients with high-risk values by using those 5 FR-DELs (DOCK8-AS1, SNHG17, RUSC1-AS1, LINC02609, and LUCAT1) (Figure 4F). This evidence concerns the gene SNHG17 and renal carcinoma.